Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q4 2016 filing in brief

In its Q4 2016 13F, filed February 14, 2017, Baupost Group reported $7.7B across 44 US positions. The largest: LNG (11.7%), VSAT (11.4%), SYF (9.8%), ALLERGAN PLC (9.4%), TWENTY FIRST CENTY FOX INC (7.0%). In the quarter it opened 13 positions, sold out of 13, added to 9 and trimmed 3; positions opened and sold out came to 20.2% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 14, 2017

  • 13 New
  • 9 Added
  • 3 Trimmed
  • 13 Exited

44 positions at December 31, 2016. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$900M21.7M11.74%−22.0%Trimmed
2VSATVIASAT INC$871M13.2M11.36%+14.1%Added
3SYFSYNCHRONY FINL$750M20.7M9.77%+17.6%Added
4—ALLERGAN PLC$721M3.4M9.40%+71.5%Added
5—TWENTY FIRST CENTY FOX INC$537M19.1M7.00%+50.1%Added
6PBFPBF ENERGY INC$438M15.7M5.72%0.0%Held
7—DELL TECHNOLOGIES INC$366M6.7M4.77%0.0%Held
8ARANTERO RES CORP$343M14.5M4.47%0.0%Held
9—THERAVANCE BIOPHARMA INC$296M9.3M3.85%+26.2%Added
10—NORTHSTAR ASSET MGMT GROUP I$279M18.7M3.64%+88.7%Added
11—NORTHSTAR RLTY FIN CORP$221M14.6M2.88%+165.1%Added
12—TWENTY FIRST CENTY FOX INC$198M7.3M2.59%0.0%Held
13VRTVEURVERITIV CORP$164M3.0M2.13%0.0%Held
14INVAINNOVIVA INC$160M14.9M2.08%0.0%Held
15—KERYX BIOPHARMACEUTICALS INC$151M25.8M1.97%0.0%Held
16—COLONY CAP INC$141M7.0M1.84%+56.5%Added
17MCKMCKESSON CORP$140M1.0M1.83%—New
18—FORWARD PHARMA A/S$81M5.4M1.05%0.0%Held
19ATRAGBXATARA BIOTHERAPEUTICS INC$76M5.4M0.99%0.0%Held
20CAHCARDINAL HEALTH INC$74M1.0M0.97%—New
21BATRKLIBERTY MEDIA CORP DELAWARE$62M3.0M0.80%0.0%Held
22—AMERICAN INTL GROUP INC$61M2.6M0.79%0.0%Held
23SYTUSDSYNGENTA AG$59M745.1K0.77%—New
24—LIBERTY INTERACTIVE CORP$55M1.5M0.71%—New
25CACCCREDIT ACCEP CORP MICH$53M244.4K0.69%+144.4%Added
26—CHIPMOS TECHNOLOGIES INC$50M3.5M0.65%—New
27—GTY TECHNOLOGY HOLDINGS INC$46M4.4M0.60%—New
28CDEVEURCENTENNIAL RESOURCE DEV INC$44M2.4M0.57%—New
29NGNOVAGOLD RES INC$43M9.5M0.56%0.0%Held
30ABGAMERISOURCEBERGEN CORP$39M502.5K0.51%—New
31INVA 2.125 01/15/23THERAVANCE INC$38M46.2M0.50%−4.1%Trimmed
32—CONYERS PK ACQUISITION$38M3.7M0.50%0.0%Held
33TBPH 3.25 11/01/23THERAVANCE BIOPHARMA INC$34M30.0M0.44%—New
34PRTKEURPARATEK PHARMACEUTICALS INC$31M2.0M0.41%0.0%Held
35—SABAN CAP ACQUISITION CORP$23M2.3M0.30%—New
36—CASCADIAN THERAPEUTICS INC$18M4.2M0.23%—New
37BATRALIBERTY MEDIA CORP DELAWARE$16M800.0K0.21%0.0%Held
38LEXEALIBERTY EXPEDIA HOLDINGS$16M395.6K0.20%—New
39RUNSUNRUN INC$15M2.8M0.20%0.0%Held
40—CITIGROUP INC$10M62.9M0.12%−38.7%Trimmed
41TMQTRILOGY METALS INC NEW$5M10.6M0.07%0.0%Held
42—OREXIGEN THERAPEUTICS INC$4M2.2M0.05%0.0%Held
43—CONYERS PK ACQUISITION$2M1.2M0.03%0.0%Held
44—SABAN CAP ACQUISITION CORP$1M1.2M0.01%—New
13 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
PYPLPAYPAL HLDGS INC$205M5.0M
OLNOLIN CORP$127M6.2M
VMWEURVMWARE INC$118M1.6M
—LIBERTY INTERACTIVE CORP$98M2.5M
—CHIPMOS TECH BERMUDA LTD$74M3.8M
—KLX INC$70M2.0M
—SILVER RUN ACQUISITION CORP$59M3.8M
ODPEUROFFICE DEPOT INC$46M13.0M
—CASCADIAN THERAPEUTICS INC$41M25.0M
—SABAN CAP ACQUISITION CORP$23M2.3M
KIN1USDKINDRED BIOSCIENCES INC$15M3.0M
—TOBIRA THERAPEUTICS INC$6M160.8K
—SILVER RUN ACQUISITION CORP$5M950.0K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.